Skip to main content

SANMINA CORP

For the period ended Jun 28, 2025. Filed Jul 28, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Jun 28, 2025 · Filed Jul 28, 2025

SANM$149.64+11.1%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Interim Financial Statements (Unaudited)

PART I. FINANCIAL INFORMATION

ITEM 1. Interim Financial Statements (Unaudited)

CONDENSED CONSOLIDATED BALANCE SHEETS

As of
June 28,2025September 28,2024
(Unaudited)
(In thousands)
ASSETS
Current assets:
Cash and cash equivalents$797,878$625,860
Accounts receivable, net of allowances of approximately $8 million and $7 million as of June 28, 2025 and September 28, 2024, respectively1,379,2871,337,562
Contract assets411,707384,077
Inventories1,589,8071,443,629
Prepaid expenses and other current assets123,20479,301
Total current assets4,301,8833,870,429
Property, plant and equipment, net629,504616,067
Deferred income tax assets154,174160,703
Other assets136,195175,646
Total assets$5,221,756$4,822,845
LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable$1,432,535$1,441,984
Accrued liabilities110,763132,513
Deferred revenue and customer advances525,144215,553
Accrued payroll and related benefits161,848133,129
Short-term debt, including current portion of long-term debt17,50017,500
Total current liabilities2,247,7901,940,679
Long-term liabilities:
Long-term debt287,183299,823
Other liabilities211,927220,835
Total long-term liabilities499,110520,658
Commitments and contingencies (Note 7)
Stockholders’ equity2,474,8562,361,508
Total liabilities and stockholders’ equity$5,221,756$4,822,845
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.